DOI: http://dx.doi.org/10.18203/2319-2003.ijbcp20201186

A retrospective study of adverse drug reactions in a tertiary care center

Ankitha L., Ramesh H.

Abstract


Background: Adverse drug reactions (ADRs) are a major concern in clinical practice. Reporting of ADRs either through health care professionals or the patients themselves is of utmost importance to give an accurate estimate of the prevalence, severity and preventability of ADRs. Present study was conducted to evaluate the prevalence of adverse drug reactions in a tertiary care hospital in Hubballi, Karnataka, India.

Methods: This was a retrospective observational study, extending over 6 months (May 2019 to October 2019). A total of 124 cases comprising patients of either sex and age group ranging from 1month to 72 years were studied. The data was collected using CDSCO ADR reporting form. “Naranjo’s Assessment Scale” was used for causality assessment and severity assessment was done in accordance with “Hartwig and Siegel scale”.

Results: The study showed majority of ADRs were from General Medicine department and affected skin and appendages (59%). Skin rashes 44 (31.7%) were found to be the most commonly reported ADRs most of them were with antimicrobials 67 (54%).  After causality assessment 83 (66.9%) of the cases were classified as probable and 41 (33.1%) were classified as possible. Majority of serious ADRs were not preventable in our study.

Conclusions: ADRs are a major cause of morbidity worldwide. Frequency of ADRs can be reduced by careful follow up and a robust hospital-based pharmacovigilance setup. Measures to improve detection and reporting of adverse drug reactions by all health care professionals is recommended.


Keywords


Adverse drug reactions, Causality, Pharmacovigilance, Preventability, Retrospective

Full Text:

PDF

References


Tripathi KD. Introduction, Routes of drug administration. In: Tripathi KD, editor. Essentials of medical pharmacology. 8th ed. New Delhi: Jaypee brothers medical publishers; 2019:481.

Kumar DP. Patterns of adverse drug reactions : a study in a tertiary care. Int J Basic Clin Pharmacol. 2019;8(7):1497-502.

Abhishake VJA, Basalingappa S, Gopi A, Daulat MP. A retrospective study of adverse drug reactions in a tertiary care centre. Int J Basic Clin Pharmacol. 2018;7(7):1339-44.

Lopez-gonzalez E, Herdeiro MT, Figueiras A. Determinants of under-reporting of adverse drug reactions: a systematic review. Drug Safety. 2009;32(1):19-31.

Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a south Indian hospital- their severity and cost involved. Pharmacoepidemol Drug safety. 2003;12:687-92.

Lihite RJ, Lahkar M. An update on the pharmacovigilance programme of India. Front Pharmacol. 2015;6(September):4-6.

Hazell L, SA S. Under reporting of adverse drug reaction: a systematic review. Drug Safety. 2006;29:385-6.

Tandon VR, Mahajan V, Khajuria V, Gillani Z. Under-reporting of adverse drug reactions : A challenge for pharmacovigilance in India. Indian J Pharmacol. 2015;47(1):65-71.

Naranjo CA, Buston U, Sellers E, Sandor P, Ruiz I, Roberts E. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(239):45.

Hartwig S, Siegel J, Schneider P. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:2229-32.

Schumock G, Thorton J. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992;49(27):538.

Prajapati K, Desai M, Panchal J, Kapadia J, Dikshit R. An analysis of serious adverse drug reactions at a tertiary care teaching hospital. Perspect Clin Res. 2016;7(4):181-6.

Raja S, Kala P. Pattern of adverse drug reactions in a tertiary care teaching hospital: a cross sectional study. Asian J Pharm Clin Res. 2017;10(3):170-3.

Venkatasubbaiah M, Reddy PD, Satyanarayana SV. Analysis and reporting of adverse drug reactions at a tertiary care teaching hospital. Alexandria J Med. 2018;54(4):597-603.

Bhabhor PH, Patel TK, Vahora R, Patel PB. Adverse drug reactions in a tertiary care teaching hospital in India : analysis of spontaneously reported cases. Int J Basic Clin Pharmacol. 2014;3(6):1078-85.

Joseph SG, Badyal DK. Spontaneous adverse drug reaction monitoring in a tertiary care hospital in Northern India. JK Sci. 2016;18(2):103-6.

Rani JR, Priya M. Hospitalization caused by adverse drug reactions in a tertiary care hospital in south india : a retrospective study. Nat J Basic Med Sci. 2013;3(3):227-30.

Sriram S, Ghasemi A, Ramasamy R, Devi M, Balasubramanian R, Ravi TK, et al. Prevalence of adverse drug reactions at a private tertiary care hospital in south India. J Res Med Sci. 2011;16(1):16-25.

Adhikari A, Bhattacharjee N, Bhattacharya S, Indu R, Ray M. Evaluation of adverse drug reactions in tertiary care hospital. J Young Pharm. 2017;9(3):311-4.

Anvesh M, Shette S. Adverse drug reaction study in tertiary care. World J Pharm Pharm Sci. 2016;5(7):1980-92.

Prashanthi B, Modi H, Kalagara D. Adverse drug reactions monitoring at tertiary care Hospital. J Drug Deliv Ther. 2019;9(1):195-8.